International Agency for Research on Cancer, 150 Cours Albert Thomas, 69372 Lyon Cedex 08, France.
Eur J Cancer. 2013 Oct;49(15):3262-73. doi: 10.1016/j.ejca.2013.04.024. Epub 2013 Jun 8.
Cervical cancer trends in a given country mainly depend on the existence of effective screening programmes and time changes in disease risk factors, notably exposure to human papillomavirus (HPV). Screening primarily influences variations by period of diagnosis, whereas changes in risk factors chiefly manifest themselves as variations in risk across successive birth cohorts of women.
We assessed trends in cervical cancer across 38 countries in five continents, age group 30-74 years, using age-standardised incidence rates (ASRs) and age-period-cohort (APC) models. Non-identifiability in APC models was circumvented by making assumptions based on a consistent relationship between age and cervical cancer incidence (i.e. approximately constant rates after age 45 years).
ASRs decreased in several countries, except in most of Eastern European populations, Thailand as well as Uganda, although the direction and magnitude of period and birth cohort effects varied substantially. Strong downward trends in cervical cancer risk by period were found in the highest-income countries, whereas no clear changes by period were found in lower-resourced settings. Successive generations of women born after 1940 or 1950 exhibited either an increase in risk of cervical cancer (in most European countries, Japan, China), no substantial changes (North America and Australia) or a decrease (Ecuador and India).
In countries where effective screening has been in place for a long time the consequences of underlying increases in cohort-specific risk were largely avoided. In the absence of screening, cohort-led increases or, stable, cervical cancer ASRs were observed. Our study underscores the importance of strengthening screening efforts and augmenting existing cancer control efforts with HPV vaccination, notably in those countries where unfavourable cohort effects are continuing or emerging.
Bill and Melinda Gates Foundation (BMGF).
一个国家的宫颈癌趋势主要取决于是否存在有效的筛查计划以及疾病风险因素的时间变化,特别是人乳头瘤病毒(HPV)的暴露。筛查主要影响诊断期的变化,而风险因素的变化主要表现为连续几代妇女的风险变化。
我们使用年龄标准化发病率(ASR)和年龄-时期-队列(APC)模型,评估了五大洲 38 个国家 30-74 岁年龄组的宫颈癌趋势。通过基于年龄与宫颈癌发病率之间的一致关系做出假设(即 45 岁后大致保持稳定的比率),来规避 APC 模型中的不可识别性。
除了东欧大部分地区、泰国和乌干达以外,一些国家的 ASR 有所下降,尽管时期和出生队列效应的方向和幅度有很大差异。在高收入国家,宫颈癌风险呈明显的时期下降趋势,而在资源较少的环境中则没有明显的时期变化。1940 年或 1950 年后出生的连续几代女性的宫颈癌风险要么增加(在大多数欧洲国家、日本、中国),要么没有明显变化(北美和澳大利亚),要么减少(厄瓜多尔和印度)。
在那些长期实施有效筛查的国家,队列特定风险增加的后果在很大程度上得到了避免。在没有筛查的情况下,观察到队列主导的风险增加或稳定的宫颈癌 ASR。我们的研究强调了加强筛查工作的重要性,并通过 HPV 疫苗接种来增强现有的癌症控制工作,特别是在那些不利的队列效应仍在继续或出现的国家。
比尔及梅林达·盖茨基金会(BMGF)。